Cite
The Role of Amyloid-β, Tau, and α-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy.
MLA
Piccarducci, Rebecca, et al. “The Role of Amyloid-β, Tau, and α-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy.” Journal of Alzheimer’s Disease, vol. 89, no. 3, Oct. 2022, pp. 1039–49. EBSCOhost, https://doi.org/10.3233/JAD-220216.
APA
Piccarducci, R., Caselli, M. C., Zappelli, E., Ulivi, L., Daniele, S., Siciliano, G., Ceravolo, R., Mancuso, M., Baldacci, F., & Martini, C. (2022). The Role of Amyloid-β, Tau, and α-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy. Journal of Alzheimer’s Disease, 89(3), 1039–1049. https://doi.org/10.3233/JAD-220216
Chicago
Piccarducci, Rebecca, Maria Chiara Caselli, Elisa Zappelli, Leonardo Ulivi, Simona Daniele, Gabriele Siciliano, Roberto Ceravolo, Michelangelo Mancuso, Filippo Baldacci, and Claudia Martini. 2022. “The Role of Amyloid-β, Tau, and α-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy.” Journal of Alzheimer’s Disease 89 (3): 1039–49. doi:10.3233/JAD-220216.